<DOC>
	<DOC>NCT01976052</DOC>
	<brief_summary>Potential biomarkers for obstructive sleep apnea (OSA), and full genomic screening will be evaluated and correlated to the degree of OSA and to effect of CPAP-treatment measured by polygraphy.</brief_summary>
	<brief_title>Evaluation of Potential Biomarkers for Obstructive Sleep Apnea and the Effect of Positive Pressure Treatment</brief_title>
	<detailed_description />
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>OSApatients with moderate and severe OSA (n=15+15) 1. Adult, 1875 years of age 2. Moderate (AHI 1530) or Severe (AHI &gt;30) OSA that are currently untreated and planned for CPAPtreatment 3. Otherwise healthy except for well controlled hypertension since 3 month, Max BP 140/90 4. Nonsmokers 5. Not pregnant 6. No medications with antioxidants 7. BMI of &lt;40 Controls (AHI&lt;5) Two groups of controls 1. Matched controls The same age, sex and BMI Â± 3 and eventual hypertension. These controls should also fulfill criteria 46 above. 2. Healthy controls with normal BMI (1925) These controls should also fulfill criteria 1., 46 above. If they no not fulfil the inclusion criteria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Biomarkers</keyword>
	<keyword>Genomics</keyword>
</DOC>